Demographic and echocardiographic characteristics of patients submitted to mitral valve repair or replacement who had previous PMC
| Variables . | Repair, n = 38 (62.3%) . | Replacement, n = 23 (37.7%) . | P-value . |
|---|---|---|---|
| Demographic | |||
| Age (years) | 48.5 ± 13.0 | 57.2 ± 10.2 | <0.0001 |
| Female sex | 35 (92.1%) | 21 (91.3%) | 0.912 |
| NYHA III–IV | 27 (71.1%) | 16 (69.6%) | 0.902 |
| Atrial fibrillation | 21 (55.3%) | 18 (78.3%) | 0.070 |
| Tricuspid disease | 9 (23.7%) | 13 (56.5%) | 0.010 |
| Aortic valve disease | 6 (15.8%) | 9 (39.1%) | 0.040 |
| More than one PMC | 3 (7.9%) | 6 (26.1%) | 0.052 |
| EuroSCORE II | 1.37 ± 0.7 | 3.13 ± 2.60 | 0.004 |
| Echocardiographic | |||
| Pure stenosis | 15 (39.5%) | 10 (43.4%) | 0.608 |
| Mitral regurgitation (degree) | 2.76 ± 1.27 | 2.78 ± 0.90 | 0.950 |
| Ejection fraction (%) | 64.8 ± 15.3% | 65.3 ± 11.4% | 0.462 |
| Left ventricular systolic diameter (mm) | 34.4 ± 8.7 | 33.2 ± 7.6 | 0.664 |
| Left ventricular diastolic diameter (mm) | 52.5 ± 10.2 | 51.0 ± 6.5 | 0.592 |
| Left atrium diameter (mm) | 53.1 ± 9.2 | 57.0 ± 9.2 | 0.208 |
| MVA (mm) | 1.30 ± 0.46 | 1.09 ± 0.42 | 0.963 |
| Systolic pulmonary artery pressure (mmHg) | 44.1 ± 8.3 | 53.7 ± 12.6 | 0.003 |
| Mitral calcification | 6 (16.2%) | 14 (60.9%) | <0.0001 |
| Echocardiographic score | 7.4 ± 1.6 | 8.2 ± 1.8 | 0.760 |
| Variables . | Repair, n = 38 (62.3%) . | Replacement, n = 23 (37.7%) . | P-value . |
|---|---|---|---|
| Demographic | |||
| Age (years) | 48.5 ± 13.0 | 57.2 ± 10.2 | <0.0001 |
| Female sex | 35 (92.1%) | 21 (91.3%) | 0.912 |
| NYHA III–IV | 27 (71.1%) | 16 (69.6%) | 0.902 |
| Atrial fibrillation | 21 (55.3%) | 18 (78.3%) | 0.070 |
| Tricuspid disease | 9 (23.7%) | 13 (56.5%) | 0.010 |
| Aortic valve disease | 6 (15.8%) | 9 (39.1%) | 0.040 |
| More than one PMC | 3 (7.9%) | 6 (26.1%) | 0.052 |
| EuroSCORE II | 1.37 ± 0.7 | 3.13 ± 2.60 | 0.004 |
| Echocardiographic | |||
| Pure stenosis | 15 (39.5%) | 10 (43.4%) | 0.608 |
| Mitral regurgitation (degree) | 2.76 ± 1.27 | 2.78 ± 0.90 | 0.950 |
| Ejection fraction (%) | 64.8 ± 15.3% | 65.3 ± 11.4% | 0.462 |
| Left ventricular systolic diameter (mm) | 34.4 ± 8.7 | 33.2 ± 7.6 | 0.664 |
| Left ventricular diastolic diameter (mm) | 52.5 ± 10.2 | 51.0 ± 6.5 | 0.592 |
| Left atrium diameter (mm) | 53.1 ± 9.2 | 57.0 ± 9.2 | 0.208 |
| MVA (mm) | 1.30 ± 0.46 | 1.09 ± 0.42 | 0.963 |
| Systolic pulmonary artery pressure (mmHg) | 44.1 ± 8.3 | 53.7 ± 12.6 | 0.003 |
| Mitral calcification | 6 (16.2%) | 14 (60.9%) | <0.0001 |
| Echocardiographic score | 7.4 ± 1.6 | 8.2 ± 1.8 | 0.760 |
NYHA: New York Heart Association; MVA: mitral valve area; PMC: percutaneous mitral commissurotomy. Bold values indicate significance of P -values ≤0.05.
Demographic and echocardiographic characteristics of patients submitted to mitral valve repair or replacement who had previous PMC
| Variables . | Repair, n = 38 (62.3%) . | Replacement, n = 23 (37.7%) . | P-value . |
|---|---|---|---|
| Demographic | |||
| Age (years) | 48.5 ± 13.0 | 57.2 ± 10.2 | <0.0001 |
| Female sex | 35 (92.1%) | 21 (91.3%) | 0.912 |
| NYHA III–IV | 27 (71.1%) | 16 (69.6%) | 0.902 |
| Atrial fibrillation | 21 (55.3%) | 18 (78.3%) | 0.070 |
| Tricuspid disease | 9 (23.7%) | 13 (56.5%) | 0.010 |
| Aortic valve disease | 6 (15.8%) | 9 (39.1%) | 0.040 |
| More than one PMC | 3 (7.9%) | 6 (26.1%) | 0.052 |
| EuroSCORE II | 1.37 ± 0.7 | 3.13 ± 2.60 | 0.004 |
| Echocardiographic | |||
| Pure stenosis | 15 (39.5%) | 10 (43.4%) | 0.608 |
| Mitral regurgitation (degree) | 2.76 ± 1.27 | 2.78 ± 0.90 | 0.950 |
| Ejection fraction (%) | 64.8 ± 15.3% | 65.3 ± 11.4% | 0.462 |
| Left ventricular systolic diameter (mm) | 34.4 ± 8.7 | 33.2 ± 7.6 | 0.664 |
| Left ventricular diastolic diameter (mm) | 52.5 ± 10.2 | 51.0 ± 6.5 | 0.592 |
| Left atrium diameter (mm) | 53.1 ± 9.2 | 57.0 ± 9.2 | 0.208 |
| MVA (mm) | 1.30 ± 0.46 | 1.09 ± 0.42 | 0.963 |
| Systolic pulmonary artery pressure (mmHg) | 44.1 ± 8.3 | 53.7 ± 12.6 | 0.003 |
| Mitral calcification | 6 (16.2%) | 14 (60.9%) | <0.0001 |
| Echocardiographic score | 7.4 ± 1.6 | 8.2 ± 1.8 | 0.760 |
| Variables . | Repair, n = 38 (62.3%) . | Replacement, n = 23 (37.7%) . | P-value . |
|---|---|---|---|
| Demographic | |||
| Age (years) | 48.5 ± 13.0 | 57.2 ± 10.2 | <0.0001 |
| Female sex | 35 (92.1%) | 21 (91.3%) | 0.912 |
| NYHA III–IV | 27 (71.1%) | 16 (69.6%) | 0.902 |
| Atrial fibrillation | 21 (55.3%) | 18 (78.3%) | 0.070 |
| Tricuspid disease | 9 (23.7%) | 13 (56.5%) | 0.010 |
| Aortic valve disease | 6 (15.8%) | 9 (39.1%) | 0.040 |
| More than one PMC | 3 (7.9%) | 6 (26.1%) | 0.052 |
| EuroSCORE II | 1.37 ± 0.7 | 3.13 ± 2.60 | 0.004 |
| Echocardiographic | |||
| Pure stenosis | 15 (39.5%) | 10 (43.4%) | 0.608 |
| Mitral regurgitation (degree) | 2.76 ± 1.27 | 2.78 ± 0.90 | 0.950 |
| Ejection fraction (%) | 64.8 ± 15.3% | 65.3 ± 11.4% | 0.462 |
| Left ventricular systolic diameter (mm) | 34.4 ± 8.7 | 33.2 ± 7.6 | 0.664 |
| Left ventricular diastolic diameter (mm) | 52.5 ± 10.2 | 51.0 ± 6.5 | 0.592 |
| Left atrium diameter (mm) | 53.1 ± 9.2 | 57.0 ± 9.2 | 0.208 |
| MVA (mm) | 1.30 ± 0.46 | 1.09 ± 0.42 | 0.963 |
| Systolic pulmonary artery pressure (mmHg) | 44.1 ± 8.3 | 53.7 ± 12.6 | 0.003 |
| Mitral calcification | 6 (16.2%) | 14 (60.9%) | <0.0001 |
| Echocardiographic score | 7.4 ± 1.6 | 8.2 ± 1.8 | 0.760 |
NYHA: New York Heart Association; MVA: mitral valve area; PMC: percutaneous mitral commissurotomy. Bold values indicate significance of P -values ≤0.05.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
